• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Celsion Corporation - Common Stock (NQ: CLSN )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Sep 20, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Celsion Corporation - Common Stock

< Previous 1 2 Next >
Important Biotech Catalysts For September 15, 2022 - End Of The Day Summary
September 15, 2022
Via Benzinga
Celsion Earnings Perspective: Return On Capital Employed
September 09, 2022
According to Benzinga Pro data, during Q2, Celsion (NASDAQ:CLSN) posted sales of $125 thousand. Earnings were up 42.31%, but Celsion still reported an overall loss of $6.04 million. 
Via Benzinga
Recap: Celsion Q2 Earnings
August 15, 2022
  Celsion (NASDAQ:CLSN) reported its Q2 earnings results on Monday, August 15, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Earnings Outlook For Celsion
August 12, 2022
  Celsion (NASDAQ:CLSN) is set to give its latest quarterly earnings report on Monday, 2022-08-15. Here's what investors need to know before the announcement. Analysts estimate that Celsion will report... 
Via Benzinga
Recap of Tuesday's Biotech Catalysts - End of the Day Summary
June 21, 2022
Ionis (NASDAQ: IONS) announced that Eplontersen met co-primary and secondary endpoints in interim analysis of the Phase 3 NEURO-TTRansform study for hereditary transthyretin-mediated amyloid... 
Via Benzinga
Celsion: Q1 Earnings Insights
May 16, 2022
Celsion (NASDAQ:CLSN) reported its Q1 earnings results on Monday, May 16, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Earnings Scheduled For May 16, 2022
May 16, 2022
Companies Reporting Before The Bell • AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at $0.06 per share on revenue of $550.00 thousand. 
Via Benzinga
Why Celsion Stock Is Surging Today
April 05, 2022
Celsion Corp (NASDAQ: CLSN) shares are trading higher Tuesday as traders circulate a Zacks Small-Cap Research note with a $37 valuation target on the stock. Zacks analyst David... 
Via Benzinga
Earnings Scheduled For August 15, 2022
August 15, 2022
Companies Reporting Before The Bell • Edible Garden (NASDAQ:EDBL) is likely to report earnings for its second quarter. 
Via Benzinga
Advanced Clinical Trials Focus on Development of Vaccines to Prevent Ovarian Cancer Progression
May 18, 2022
Palm Beach, FL – May 18, 2022 – FinancialNewsMedia.com News Commentary – Companies in the Ovarian Cancer market are spending a lot of R&D on vaccine development, therapies and studies. For the past 30... 
Via FinancialNewsMedia
Topics Death
Exposures Death
Earnings Outlook For Celsion
May 13, 2022
Celsion (NASDAQ:CLSN) is set to give its latest quarterly earnings report on Monday, 2022-05-16. Here's what investors need to know before the announcement. Analysts estimate that Celsion will report... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
April 21, 2022
Gainers 
Via Benzinga
Celsion: Q4 Earnings Insights
March 31, 2022
  Celsion (NASDAQ:CLSN) reported its Q4 earnings results on Thursday, March 31, 2022 at 08:30 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Celsion's Formulated DNA Plasmid COVID-19 Vaccine Candidate Shows Activity Against Two Strains
April 21, 2022
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
April 21, 2022
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
April 20, 2022
Gainers 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 13, 2022
April 13, 2022
Upgrades 
Via Benzinga
The Week Ahead In Biotech (April 10-April 16): Regeneron FDA Decision, Cancer Conference Presentations And More
April 10, 2022
Biotech stocks managed to carve out modest gains for the week ending April 8, defying the broader market weakness. The defensive nature of the stocks make them appealing in times of risk aversion. 
Via Benzinga
53 Biggest Movers From Yesterday
April 08, 2022
Gainers MedAvail Holdings, Inc. (NASDAQ: MDVL) shares surged 64.4% to close at $1.41 on Thursday. Ally Bridge Group reported a purchase of 21.176 million shares of MedAvail... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
April 07, 2022
Gainers Trevi Therapeutics (NASDAQ:TRVI) stock rose 45.8% to $2.77 during Thursday's regular session. Trevi Therapeutics's stock is trading at a volume of 15.2... 
Via Benzinga
51 Biggest Movers From Yesterday
April 07, 2022
Gainers Advent Technologies Holdings, Inc. (NASDAQ: ADN) shares climbed 79.7% to close at $3.63 on Wednesday. Advent Technologies and Hyundai Motor Company entered into... 
Via Benzinga
Mid-Afternoon Market Update: Crude Oil Down 5%; Celsion Shares Plummet
April 06, 2022
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping 150 points on Wednesday. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
April 06, 2022
Gainers Sunshine Biopharma (NASDAQ:SBFM) shares rose 32.4% to $7.43 during Wednesday's regular session. Sunshine Biopharma's stock is trading at a volume of 46.8... 
Via Benzinga
40 Stocks Moving In Wednesday's Mid-Day Session
April 06, 2022
Gainers Advent Technologies Holdings, Inc. (NASDAQ: ADN) shares jumped 77.7% to $3.5950. Advent Technologies and Hyundai Motor Company entered into technology assessment, sales... 
Via Benzinga
Why Celsion Shares Are Pulling Back Today
April 06, 2022
Celsion Corp (NASDAQ: CLSN) shares are trading lower Wednesday after the company announced a $7 million registered direct offering priced at-the-market under Nasdaq rules.... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
April 06, 2022
Gainers Healthcare Triangle (NASDAQ:HCTI) stock moved upwards by 17.5% to $1.35 during Wednesday's pre-market session. The company's market cap stands at $47.6... 
Via Benzinga
51 Biggest Movers From Yesterday
April 06, 2022
Gainers Sunshine Biopharma, Inc. (NASDAQ: SBFM) shares surged 148.2% to close at $5.61 on Tuesday after the company announced that two of its designed mRNA molecules are... 
Via Benzinga
Celsion's Return On Capital Employed Insights
April 01, 2022
According to Benzinga Pro data, during Q4, Celsion (NASDAQ:CLSN) posted sales of $125.00 thousand. Earnings were up 21.98%, but Celsion still reported an overall loss of $4.22 million. 
Via Benzinga
Earnings Scheduled For March 31, 2022
March 31, 2022
Companies Reporting Before The Bell • Trevena (NASDAQ:TRVN) is likely to report earnings for its fourth quarter. 
Via Benzinga
Celsion's Earnings Outlook
March 30, 2022
Celsion (NASDAQ:CLSN) is set to give its latest quarterly earnings report on Thursday, 2022-03-31. Here's what investors need to know before the announcement. Analysts estimate that Celsion will report... 
Via Benzinga
< Previous 1 2 Next >
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap